FDA Releases Revised Guidance about Animal Drug User Fees, Fee Waivers and Reductions The FDA has issued a revised version of Guidance for Industry #170: Animal Drug User Fees and Fee Waivers and Reductions, finalizing the revisions proposed in the draft revised guidance issued in November 2016. GFI #170 describes the types of fees that the FDA is authorized to collect under the Animal Drug User Fee Act of 2003 and how to request waivers and reductions of these fees. |